CD8A and hepatocellular carcinoma: The global ability of CD8+ T cells from HCC patients to respond to stimulation was verified using the positive control MelanA peptide, and no significant difference was observed between HCC patients and HD in MelanA-specific CD8+ T cells expansion using the irradiated and peptide-loaded PDC*line (Supplemental Figure S3, http://links.lww.com/HC9/B913).